Skeletal isomerisation of oleic acid over ferrierite : Influence of acid site number, accessibility and strength on activity and selectivity

Protonated ferrierite shows superior activity and selectivity in the liquid-phase isomerisation of linear unsaturated fatty acids to (mono-)branched-chain unsaturated fatty acids, (Mo)BUFA. This high selectivity is remarkable, as most of the interior surface of the zeolite is blocked already at the onset of reaction, limiting reaction to the pore mouth. A detailed study of the relationship between ferrierite acidity and performance is reported for five commercial catalysts; significant differences were found, independently of their bulk Si/AI ratios. Initial pore conversion correlates with Bronsted acidity in the 10-MR channels, as determined by adsorption/desorption of pyridine and FTIR. A low density of external acid sites reduces oligomerisation of fatty acids, while a high ratio of Bronsted to Lewis sites explains the observed high BUFA yield. The combination of FTIR with CO adsorption, and temperature-programmed desorption of NH3, confirms that the presence of strong but few Bronsted acid sites in the 10-MR channels increases selectivity to MoBUFA. (C) 2015 Elsevier Inc. All rights reserved

Rb and FZR1/Cdh1 determine CDK4/6-cyclin D requirement in C. elegans and human cancer cells

Cyclin-dependent kinases 4 and 6 (CDK4/6) in complex with D-type cyclins promote cell cycle entry. Most human cancers contain overactive CDK4/6-cyclin D, and CDK4/6-specific inhibitors are promising anti-cancer therapeutics. Here, we investigate the critical functions of CDK4/6-cyclin D kinases, starting from an unbiased screen in the nematode Caenorhabditis elegans. We found that simultaneous mutation of lin-35, a retinoblastoma (Rb)-related gene, and fzr-1, an orthologue to the APC/C co-activator Cdh1, completely eliminates the essential requirement of CDK4/6-cyclin D (CDK-4/CYD-1) in C. elegans. CDK-4/CYD-1 phosphorylates specific residues in the LIN-35 Rb spacer domain and FZR-1 amino terminus, resembling inactivating phosphorylations of the human proteins. In human breast cancer cells, simultaneous knockdown of Rb and FZR1 synergistically bypasses cell division arrest induced by the CDK4/6-specific inhibitor PD-0332991. Our data identify FZR1 as a candidate CDK4/6-cyclin D substrate and point to an APC/C(FZR1) activity as an important determinant in response to CDK4/6-inhibitors